PROPIONIC ACIDEMIA FOUNDATION

Finding better treatments and a cure for Propionic Acidemia since 2003 The Propionic Acidemia Foundation is a 501(c)3 non-profit organization dedicated to finding improved treatments and a cure for Propionic Acidemia by funding research and providing information and support to families and medical professionals.

• Community Health Systems

• 650.

Oneida Health Care Corporation

THE MISSION OF ONEIDA HEALTHCARE CORPORATION IS TO RESPOND TO THE SHORTAGE OF DECENT, SAFE AND SANITARY HEALTHCARE FACILITIES BY PLANNING, CONSTRUCTING, OWNING, AND FINANCING HEALTHCARE FACILITIES FOR THE USE OF ONEIDA HEALTH.

• Nonmonetary Support N.E.C.*

• 651.

Windber Research Institute

Our vision is to impact healthcare and improve quality of life through research.

• Fund Raising and/or Fund Distribution

• 652.

Curemito

Our mission is to unite the global Leigh syndrome community to accelerate patient-centered research, treatments, and cures.

• Management & Technical Assistance

• 653.

Pathways Corp

To elevate the patient's voice to increase access to care and eliminate bias by bringing stakeholders together Home Our Team Events Initiatives Partners Media Kit Contact More Its Time to Listen to the Rare Disease Community.

• Private Independent Foundations

• 654.

Joseph P Roberson Foundation

1000000 given to the UC Davis HD Clinic.

• Education N.E.C.

• 655.

ASSOCIATION FOR MOLECULAR PATHOLOGY INC

We provide global expertise in molecular testing that drives patient care.

UVA COMMUNITY HEALTH FOUNDATION

An integrated health system with an academic medical center, three community hospitals, and primary and specialty care clinics throughout Virginia Search Donate Search This Site HONORTHE FUTURE The Campaign for the University of Virginia Its time to invest in the search for a cure.

• Promotion of Business (Chambers of Commerce)

• 657.

INDUSTRY PHARMACOGENOMICS WORKING GROUP

Welcome To The Pharmacogenomic Working Group The Industry Pharmacogenomics Working Group IPWG is an association of pharmaceutical and biotech companies who are actively engaged in the field of pharmacogenomic PGx research.